The effects of treatment with chemical agents or infection with feline viruses on protein-binding properties of the feline immunodeficiency virus long terminal repeat

Virus Research

Volumn 51, Issue 2, 1997, Pages 203-212

  Ikeda, Yasuhiro ^a   Kawaguchi, Yasushi ^a,b   Inoshima, Yasuo ^a   Kohmoto, Mariko ^a   Shimojima, Masayuki ^a   Inada, Gouki ^a   Sato, Eiji ^a   Kai, Chieko ^a   Miyazawa, Takayuki ^a   Mikami, Takeshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

AP 1; FHV 1; FIV; Forskolin; LBP 1; TPA

Indexed keywords

CHEMICAL AGENT; FORSKOLIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CAT; CELL CULTURE; CELL LINE; FELINE IMMUNODEFICIENCY VIRUS; GEL ELECTROPHORESIS; IN VITRO STUDY; KIDNEY CELL; LENTIVIRINAE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; VIRUS INFECTION;

ANIMALS; BINDING SITES; CATS; CELL LINE; FORSKOLIN; HERPESVIRIDAE; IMMUNODEFICIENCY VIRUS, FELINE; NUCLEAR PROTEINS; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; REPETITIVE SEQUENCES, NUCLEIC ACID; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC;

ANIMALIA; FELIDAE; FELINE HERPESVIRUS 1; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HERPESVIRIDAE; LENTIVIRUS;

EID: 0031259659     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00094-4     Document Type: Article

References (44)

1. Barry, P.A., Pratt-Lowe, E., Peterlin, B.M., Luciw, P.A., 1990. Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 64, 2932-2940.
2. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., Nishizuka, Y., 1982. Direct activation of calcium-activated phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257, 7847-7851.
3. Crandell, R.A., Fabricant, C.G., Nelson-Ree, W.A., 1973. Development, characterization, and viral susceptibility of a feline (felis catus) renal cell line (CRFK). In Vitro 9, 176-185.
4. Cullen, B.R., Greene, W.C., 1989. Regulatory pathways governing HIV-1 replication. Cell 58, 423-426.
5. English, R.V., Nelson, P., Johnson, C.M., Nasisse, M., Tompkins, W.A., Tompkins, M.B., 1994. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J. Infect. Dis. 170, 543-552.
6. Fong, S.E., Pallansch, L.A., Mikovits, J.A., Lackman-Smith, C.S., Ruscetti, F.W., Gonda, M.A., 1995. Cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat. Virology 209, 604-614.
7. Graham, F.L., van der Eb, A.J., 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
8. Hai, T., Liu, F., Allegretto, E.A., Karin, M., Green, M.R., 1988. A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev. 2, 1216-1226.
9. Hai, T., Curran, T., 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88, 3720-3724.
10. Hayward, G.S., 1993. Immediate-early gene regulation in herpes simplex virus. Semin. Virol. 4, 15-23.
11. Ikeda, Y., Kawaguchi, Y., Tomonaga, K., Inoshima, Y., Kohmoto, M., Miyazawa, T., Mikami, T., 1996. Regulatory properties of the integrated long terminal repeat of the feline immunodeficiency virus. Virus Res. 41, 201-207.
12. Ikeda, Y., Inoshima, Y., Kawaguchi, Y., Maeda, K., Kohmoto, M., Miyazawa, T., Kai, C., Mikami, T., 1997. Protein-binding properties of the putative AP-1 and ATF sequences in the feline immunodeficiency virus long terminal repeat. J. Gen. Virol. In press.
13. Inoshima, Y., Kohmoto, M., Ikeda, Y., Yamada, H., Kawaguchi, Y., Tomonaga, K., Miyazawa, T., Kai, C., Umemura, T., Mikami, T., 1996. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats. J. Virol. 70, 8518-8526.
14. Kawaguchi, Y., Miyazawa, T., Horimoto, T., Itagaki, T., Fukasawa, M., Takahashi, E., Mikami, T., 1991. Activation of feline immunodeficiency virus long terminal repeat by feline herpesvirus type 1. Virology 184, 449-454.
15. Kawaguchi, Y., Norimine, J., Miyazawa, T., Kai, C., Mikami, T., 1992. Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1. Virology 190, 465-468.
16. Kawaguchi, Y., Mikami, T., 1995. Molecular interactions between retroviruses and herpesviruses. J. Vet. Med. Sci. 57, 801-811.
17. Kawaguchi, Y., Tomonaga, K., Maeda, K., Ono, M., Miyazawa, T., Kohmoto, M.,Tohya, Y., Mikami, T., 1995. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4. Virology 208, 492-499.
18. Kiyomasu, T., Miyazawa, T., Furuya, T., Shibata, R., Sakai, H., Sakuragi, J., Fukasawa, M., Maki, N., Hasegawa, A., Mikami, T., Adachi, A., 1991. Identification of feline immunodeficiency virus rev gene activity. J. Virol. 65, 4539-4542.
19. Maki, N., Miyazawa, T., Fukasawa, M., Hasegawa, A., Hayami, M., Miki, K., Mikami, T., 1992. Molecular characterization and heterogeneity of feline immunodeficiency virus isolates. Arch. Virol. 123, 29-45.
20. Margolis, D.M., Rabson, A.B., Straus, S.E., Ostrove, J.M., 1992. Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes. Virology 186, 788-791.
21. Margolis, D.M., Ostrove, J.M., Straus, S.E., 1993. HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element. Virology 192, 370-374.
22. Mermoid, N., Williams, T.J., Tjian, R., 1988. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332, 557-561.
23. Miyazawa, T., Furuya, T., Itagaki, S., Tohya, Y., Takahashi, E., Mikami, T., 1989. Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch. Virol. 108, 131-135.
24. Miyazawa, T., Fukasawa, M., Hasegawa, A., Maki, N., Ikuta, K.,Takahashi, E., Hayami, M., Mikami, T., 1991. Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original US isolate. J. Virol. 65, 1572-1577.
25. Miyazawa, T., Mikami, T., 1993. Biological nature of feline immunodeficiency virus. J. Vet. Med. Sci. 55, 519-526.
26. Miyazawa, T., Kohmoto, M., Kawaguchi, Y., Tomonaga, K., Toyosaki, T., Ikuta, K., Adachi, A., Mikami, T., 1993. The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes. J. Gen. Virol. 74, 1573-1580.
27. Miyazawa, T., Tomonaga, K., Kawaguchi, Y., Mikami, T., 1994. The genome of feline immunodeficiency virus. Arch. Virol. 134, 221-234.
28. Olmsted, R.A., Barnes, A.K., Yamamoto, J.K., Hirsch, V.M., Purcell, R.H., Johnson, P.R., 1989. Molecular cloning of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86, 2448-2452.
29. Ostrove, J.M., Leonard, J., Weck, K.E., Rabson, A.B., Gendelman, H.E., 1987. Activation of the human immunodeficiency virus by herpes simplex virus type 1. J. Virol. 61, 3726-3732.
30. Pavlakis, G.N., Felber, B.K., 1990. Regulation of expression of human immunodeficiency virus. New Biol. 2, 20-31.
31. Piette, J., Hirai, S., Yaniv, M., 1988. Constitutive synthesis of activator protein 1 transcription factor after viral transformation of mouse fibroblasts. Proc. Natl. Acad. Sci. USA 85, 3401-3405.
32. Phillips, T.R., Talbott, R.L., Lamont, C., Muir, S., Lovelace, K., Elder, J.H., 1990. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64, 4605-4613.
33. Phillips, T.R., Lamont, C., Konings, D.A.M., Shacklett, B.L., Hamson, C.A., Luciw, P.A., Elder, J.H., 1992. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66, 5464-5471.
34. Roesler, W.J., Vandenbark, G.R., Hanson, R.W., 1988. Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263, 9063-9066.
35. Seamon, K.B., Daly, J.W., 1986. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Phosphor. Res. 20, 1-150.
36. Sparger, E.E., Shacklett, B.L., Renshaw, G.L., Barry, P.A., Pedersen, N.C., Elder, J.H., Luciw, P.A., 1992. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 187, 165-177.
37. Sparger, E.E., 1993. Current thoughts on feline immunodeficiency virus infection. Vet. Clin. North Am. Small Anim. Prac. 23, 173-191.
38. Thompson, F.J., Elder, J., Neil, J.C., 1994. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat. J. Gen. Virol. 75, 545-554.
39. Tomonaga, K., Shin, Y.S., Fukasawa, M., Miyazawa, T., Adachi, A., Mikami, T., 1993a. Feline immunodeficiency virus gene expression: analysis of the RNA splicing pattern and the monocistronic rev mRNA. J. Gen. Virol. 74, 2409-2417.
40. Tomonaga, K., Miyazawa, T., Sakuragi, J., Mori, T., Adachi, A., Mikami, T., 1993b. The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and Peripheral blood lymphocytes. J. Virol. 67, 5889-5895.
41. Tomonaga, K., Mikami, T., 1996. Molecular biology of the feline immunodeficiency virus auxiliary genes. J. Gen. Virol. 77, 1611-1621.
42. Vlach, J., Pitha, P.M., 1993. Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus. J. Virol. 67, 4427-4431.
43. Willey, R.L., Smith, D.H., Lasky, L.A., Theodora, T.S., Earl, P.L., Moss, B., Capon, D.J., Martin, M.A., 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62, 139-147.
44. Willett, B.J., Hosie, M.J., Neil, J.C., Turner, J.D., Hoxie, J.A., 1997. Common mechanism of infection by lentiviruses. Nature 385, 587.